Yuhan Corporation operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yuhan with three other
pharmaceutical manufacturers in Asia:
Green Cross Holdings Corporation
sales of 1.13 trillion Korean Won [US$956.64 million]
China Resources Double-Crane Pharmaceutical Company Limited
(5.14 billion Chinese Renmimbi [US$744.32 million]
of which 52%
was Transfusion), and
Apeloa Pharmaceutical Co Ltd
based in China
(4.34 billion Chinese Renmimbi [US$628.50 million]
of which 100%
was Health Care & Pharmaceutical).
Yuhan reported sales of 1.13 trillion Korean Won (US$953.78 million)
December of 2015.
increase of 10.9%
versus 2014, when the company's sales were 1.02 trillion Korean Won.
Sales at Yuhan have increased during each of the previous five years
(and since 2010, sales have increased a total of 70%).